Rare diseases
Investigational molecules
Locations
Back to Croatia257 clinical trials in Zagreb, Croatia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
CroatiaStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
CroatiaCroatiaStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
CroatiaA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
CroatiaCroatiaA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
CroatiaA study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes
CroatiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
CroatiaStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
CroatiaStudy comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis
CroatiaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on autoimmune disorders encompass treatments for psoriatic arthritis, Sjögren's Syndrome, and systemic lupus erythematosus, evaluating novel therapeutic approaches for improved patient outcomes.
These trials aim to assess new biological medicines and their effectiveness in managing chronic inflammatory conditions.
Research initiatives targeting neurological conditions focus on multiple sclerosis and Alzheimer's disease-related psychosis, exploring innovative treatment approaches for better disease management.
Studies evaluate both established and emerging treatments to improve patient outcomes and quality of life.
Advanced cancer research programs examine treatments for lung cancer, leukemia, and thyroid cancer, investigating targeted therapies and combination treatments.
These trials focus on improving survival rates and developing more effective treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
